Organization
Silver Spring, MD
7 abstracts
Abstract
Project Facilitate: An analysis of the increased utilization in the oncology single patient expanded access pathway.Org: U.S. Food and Drug Administration, Oncology Center of Excellence, Silver Spring, MD, Office of the Commissioner,
Abstract
FDA analysis of immune checkpoint inhibitors in combination with vascular endothelial growth factor tyrosine kinase inhibitors in the second-line treatment of patients with advanced non-small cell lung cancer.Org: U.S. Food and Drug Administration, Silver Spring, MD, Office of Oncologic Diseases, Center for Drug Evaluation and Research, Oncology Center of Excellence,
Abstract
Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.Org: Fred Hutchinson Cancer Research Center, Seattle, WA, American Society of Clinical Oncology, Alexandria, VA, Friends of Cancer Research, Washington, DC,
Abstract
Trends in new and persistent opioid use in older adults with cancer.Org: Yale School of Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New Haven, CT, Cancer Outcomes, Public Policy and Effectiveness Research Center, Public Policy and Effectiveness Research (COPPER) Center,
Abstract
Differences in perceptions and use of remote patient monitoring technology in rural cancer programs.Org: Penn State Health Milton S. Hershey Medical Center, Hershey, PA, Association of Community Cancer Centers (ACCC), Rockville, MD, Rockville, MD, Rhizome, LLC,
Abstract
FDA analysis of treatment efficacy based on etiology of hepatocellular carcinoma.Org: US Food and Drug Administration, Silver Spring, MD, FDA/CDER, Center for Drug Evaluation and Research, U.S. Food and Drug Administration,
Abstract
Bridging the gap: FDA diversity-related postmarketing requirements.Org: U.S. Food and Drug Administration, Silver Spring, MD, MD Anderson Cancer Center, US Food and Drug Administration, Food and Drug Administration,